BACKGROUND: The extent of inappropriate prescribing observed in geriatric medicine has not been thoroughly evaluated in people ageing with HIV. We determined the prevalence of and risk factors for inappropriate prescribing in individuals aged ≥75 years enrolled in the Swiss HIV Cohort Study. METHODS: Retrospective review of medical records was performed to gain more insights into non-HIV comorbidities. Inappropriate prescribing was screened using the Beers criteria, the STOPP/START criteria and the Liverpool drug-drug interactions (DDIs) database. RESULTS: For 175 included individuals, the median age was 78 years (IQR 76-81) and 71% were male. The median number of non-HIV comorbidities was 7 (IQR 5-10). The prevalence of polypharmacy and ...
Background: Geriatric Patients Living with HIV/AIDS (GEPPO) is a new prospective observational multi...
Objectives To compare the use of co-medication, the potential drug-drug interactions (PDDIs) and the...
OBJECTIVES People with HIV (PWHIV) are likely to need therapies for comorbidities as they age. We...
BACKGROUND: The extent of inappropriate prescribing observed in geriatric medicine has not been thor...
The extent of inappropriate prescribing observed in geriatric medicine has not been thoroughly evalu...
Antiretroviral therapy has transformed HIV infection from a deadly into a chronic condition. Aging p...
Antiretroviral therapy has transformed HIV infection from a deadly into a chronic condition. Aging p...
Introduction: Combined antiretroviral therapy has transformed HIV infection into a chronic disease t...
We assessed the prevalence of potentially inappropriate prescriptions (PIP) among older (≥ 65 years)...
Introduction; : Combined antiretroviral therapy has transformed HIV infection into a chronic disease...
Summary: Background: Polypharmacy, defined as use of five or more medications concurrently, is asso...
The availability of potent antiretroviral therapy has transformed HIV infection into a chronic disea...
ObjectivesTo describe the frequency of medication-related problems in older adults with human immuno...
INTRODUCTION:The availability of potent antiretroviral therapy has transformed HIV infection into a ...
INTRODUCTION:Multimorbidity in advanced age and the need for drug treatment may lead to polypharmacy...
Background: Geriatric Patients Living with HIV/AIDS (GEPPO) is a new prospective observational multi...
Objectives To compare the use of co-medication, the potential drug-drug interactions (PDDIs) and the...
OBJECTIVES People with HIV (PWHIV) are likely to need therapies for comorbidities as they age. We...
BACKGROUND: The extent of inappropriate prescribing observed in geriatric medicine has not been thor...
The extent of inappropriate prescribing observed in geriatric medicine has not been thoroughly evalu...
Antiretroviral therapy has transformed HIV infection from a deadly into a chronic condition. Aging p...
Antiretroviral therapy has transformed HIV infection from a deadly into a chronic condition. Aging p...
Introduction: Combined antiretroviral therapy has transformed HIV infection into a chronic disease t...
We assessed the prevalence of potentially inappropriate prescriptions (PIP) among older (≥ 65 years)...
Introduction; : Combined antiretroviral therapy has transformed HIV infection into a chronic disease...
Summary: Background: Polypharmacy, defined as use of five or more medications concurrently, is asso...
The availability of potent antiretroviral therapy has transformed HIV infection into a chronic disea...
ObjectivesTo describe the frequency of medication-related problems in older adults with human immuno...
INTRODUCTION:The availability of potent antiretroviral therapy has transformed HIV infection into a ...
INTRODUCTION:Multimorbidity in advanced age and the need for drug treatment may lead to polypharmacy...
Background: Geriatric Patients Living with HIV/AIDS (GEPPO) is a new prospective observational multi...
Objectives To compare the use of co-medication, the potential drug-drug interactions (PDDIs) and the...
OBJECTIVES People with HIV (PWHIV) are likely to need therapies for comorbidities as they age. We...